Riskpilot← Back to searchSign inGet full accessDECAMIN TRADING ApS
APSActiveCVR 66614115Vesterhedenvej 64Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19810 employees
Revenue 2024
DKK 51K
-63% vs 2023
EBITDA margin
-40.4%
-135% vs 2023
Equity ratio
57.0%
Financial strength
Net profit 2024
DKK -3K
-27% vs 2023
| Revenue | DKK 51K | -63% |
| EBITDA | DKK -20K | -135% |
| Net profit | DKK -3K | -27% |
| Total assets | DKK 2,5M | -9% |
| Equity | DKK 1,4M | +0% |
| Employees | 0 | — |
Legal name
DECAMIN TRADING ApS
CVR number
66614115
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. januar 1981
Share capital
DKK 200.000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at drive handel og industri
Address
Vesterhedenvej 64
Phone
+4598385758
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 183 | 114 | -10 | 126 | 58 | 82 | -40 | 166 | 38 | 217 | 1.607 | 137 | 51 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -90 | -60 | -173 | -76 | -124 | -1.520 | -78 | -71 |
| EBITDA | 183 | 114 | -10 | 126 | 58 | -7 | -100 | -7 | -38 | 93 | 86 | 59 | -20 |
| Depreciation & amort. | -0 | -7 | -0 | -8 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 183 | 107 | -11 | 119 | 58 | -7 | -100 | -7 | -38 | 93 | 86 | 59 | -20 |
| Net financials | -30 | 43 | 39 | 34 | -2 | 3 | -0 | -7 | -4 | -7 | -19 | -4 | 17 |
| Profit before tax | 153 | 150 | 28 | 153 | 55 | -5 | -100 | -14 | -42 | 86 | 67 | 55 | -3 |
| Tax | 35 | 37 | 4 | 35 | 10 | -0 | -22 | -4 | -10 | 19 | 14 | 57 | -1 |
| Net profit | 118 | 113 | 25 | 118 | 45 | -5 | -78 | -9 | -32 | 68 | 53 | -2 | -3 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.744 | 2.027 | 2.061 | 2.235 | 1.619 | 1.679 | 1.677 | 2.088 | 1.628 | 4.054 | 2.959 | 2.730 | 2.480 |
| Equity | 929 | 1.042 | 1.067 | 1.184 | 1.229 | 1.225 | 1.146 | 1.329 | 1.297 | 1.365 | 1.418 | 1.416 | 1.413 |
| Long-term debt | 686 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.129 | 985 | 994 | 1.051 | 390 | 454 | 530 | 760 | 331 | 2.690 | 1.542 | 1.315 | 1.067 |
| Total debt | 1.815 | 985 | 994 | 1.051 | 390 | 454 | 530 | 760 | 331 | 2.690 | 1.542 | 1.315 | 1.067 |
EBITDA margin
-40.4%
This company
15.8%
Market median
-356% vs market
20122024
Equity ratio
57.0%
This company
38.2%
Market median
+49% vs market
20122024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20122024
Net profit margin
-5.0%
This company
8.1%
Market median
-162% vs market
20122024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20122024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FH Audit | Audit | 1981 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 1981 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DECAMIN TRADING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Harlis | Audit | 0 companies |